BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors

Industry veteran brings extensive technical operations scale-up experience and extreme fluency in cell therapy tools and services selection process BOTHELL, Wash., Aug. 25, 2022 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and…

About the Author

has written 41538 stories on this site.

Copyright © 2010 Business and Corporate News.